Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022165494 - SALT CRYSTALS

Publication Number WO/2022/165494
Publication Date 04.08.2022
International Application No. PCT/US2022/070368
International Filing Date 27.01.2022
IPC
C07D 519/00 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
519Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/ or C07D455/257
A61K 31/437 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
C07D 401/14 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
14containing three or more hetero rings
CPC
A61K 31/519
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
C07C 55/07
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
55Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
02Dicarboxylic acids
06Oxalic acid
07Salts thereof
C07C 55/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
55Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
02Dicarboxylic acids
10Succinic acid
C07C 55/14
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
55Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
02Dicarboxylic acids
14Adipic acid
C07C 55/20
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
55Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
02Dicarboxylic acids
20Sebacic acid
C07C 57/145
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
57Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
02with only carbon-to-carbon double bonds as unsaturation
13Dicarboxylic acids
145Maleic acid
Applicants
  • INTRA-CELLULAR THERAPIES, INC. [US]/[US]
Inventors
  • LI, Peng
Agents
  • LEE, Sangil
Priority Data
63/142,07327.01.2021US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) SALT CRYSTALS
(FR) CRISTAUX DE SEL
Abstract
(EN) The present disclosure relates to free base and salt crystals of 2-(4-acetylbenzyl)-3-((4-fluorophenyl)amino)-5,7,7-trimethyl-7,8-dihydro-2H-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one, composition comprising the same and the method of making and using such free base and salt crystals.
(FR) La présente invention concerne des cristaux de sel et à base libre de 2-(4-acétylbenzyle)-3-((4-fluorophényl)amino)-5,7,7-triméthyl-7,8-dihydro-2H-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one, une composition les comprenant et le procédé de fabrication et d'utilisation desdits cristaux de sel et à base libre.
Latest bibliographic data on file with the International Bureau